The producer of the Yellow Fever vaccine, Sanofi, recently advised the United Kingdom’s National Travel Health Network and Centre (NaTHNaC) that the yellow fever vaccine Stamaril® (17D-YFV, 17D-213) is expected to be available for ordering in the UK by August 15, 2025.
Since August 1, 2025, the UK has had limited access to Stamaril.
The NaTHNaC says this YF vaccine’s availability is subject to change, and this should be taken into account when advising the traveller. Where a provider is unable to provide the YF vaccine during this vaccine shortage, the provider is expected to proactively research alternative supplies in their locality and direct international travellers accordingly.
If attempts to source the YF vaccine are unsuccessful, health professionals can contact the NaTHNaC advice line to discuss with an advisor.
Regardless of vaccine access in the UK, various countries, such as Brazil and Colombia, require proof of YF vaccination upon arrival in 2025.
As of August 10, 2025, the travel vaccination centers in the United States have access to the YF-VAX vaccine, which Sanofi also produces.